Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/5784
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYimer, Getnet-
dc.contributor.authorEkuadzi, Edmund-
dc.contributor.authorFasinu, Pius-
dc.contributor.authorMelo, Andreia Cristina de-
dc.contributor.authorGoonaseelan (Colin), Pillai-
dc.date.accessioned2022-03-15T19:34:16Z-
dc.date.available2022-03-15T19:34:16Z-
dc.date.issued2021-
dc.identifier.issn1365-2125-
dc.identifier.otherDOI: 10.1111/bcp.14981-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/5784-
dc.description.abstractThere has been high interest in the use of traditional medicines for COVID-19 from early in the course of the pandemic. Significant advances in the science of ethnopharmacology have helped to introduce chemical entities identified from natural sources into modern medicine. However, the wider integration of natural products into the modern drug discovery process will require enhanced collaboration amongst the pharmaceutical industry, academic research units, regulatory bodies, ethics review committees and local, regional, continental and international organizations. Revisiting this topic holds promise of benefit for both the current and future pandemicspt_BR
dc.language.isoenpt_BR
dc.publisherBr J Clin Pharmacol.pt_BR
dc.subjectCOVID-19pt_BR
dc.subjectProdutos Biológicospt_BR
dc.subjectBiological Productspt_BR
dc.subjectMedicina Tradicionalpt_BR
dc.subjectMedicine Traditionalpt_BR
dc.subjectSARS-Cov-2pt_BR
dc.subjectFitoterapiapt_BR
dc.subjectPhytotherapypt_BR
dc.titleTraditional medicines for COVID-19: Perspectives from clinical pharmacologistspt_BR
dc.TypeArticlept_BR
Appears in Collections:Artigo de Periódicos da Pesquisa Clínica

Files in This Item:
File Description SizeFormat 
Traditional medicines for COVID-19 Perspectives from clinical pharmacologists.pdf573.36 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.